A clinical trial to compare the effect of a bone regenerating material in two different ratios in the treatment of bone loss in permanent teeth.
- Conditions
- Health Condition 1: K051- Chronic gingivitis
- Registration Number
- CTRI/2022/12/048196
- Lead Sponsor
- Dr Anshika Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Patients with good systemic and mental health with no systemic diseases that could influence the outcome of the therapy. Patients having Glickmanâ??s Grade II Molar Furcation involvement with horizontal probing depth of more than or equal to 3mm and vertical probing depth of more than or equal to 4mm.
Patients who are maintaining oral hygiene, after the re-evaluation of phase I therapy with Plaque index (PI) score less than 1.
Patients who have not undergone any surgical periodontal therapy in last 6 months.
Patients who had no known history of allergy to any of the materials used.
Patients who are ready to sign informed consent and will be able to follow written or verbal instructions.
Debilitating systemic or infectious diseases (HIV or hepatitis) or any diseases that affect the periodontium.
Poor compliance or failure to maintain good oral hygiene.
Use of tobacco products either in smoking or smokeless forms.
Patients taking immunosuppressive drugs or corticosteroids which may compromise the treatment outcome.
History of a previous root coverage procedure, graft or GTR involving the recession site.
A known allergy to any of the materials used in the study.
Pregnancy or lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvements in clinical parametersTimepoint: 12 weeks and 24 weeks
- Secondary Outcome Measures
Name Time Method Bone fillTimepoint: 24 weeks